Two Top Stories of Wall Street: Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), The Clorox Company (NYSE:CLX)

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA)

The shares of Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) started off the last trading session with the price of $14.48 while closing the day with the price of $13.87. The shares of Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) Fell -1.77% with the Loss of -0.61 points.

The shares of Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) traded with the day volume of 372943 shares whereas its average trading volume is 412.67 Million.

While analyzing the past performance of the stock we can see that the shares of Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) Gain 1.17% in the last week while rising 45.08% in the last month. Past quarter performance shows the green light with 81.54%. The semi-annual and annual performance shows 291.81% and 367% respectively.

Some critical values of the shares of Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) to be discussed here are: the beta which shows the value at 2.17 while Average True Range of Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) demonstrate the value at 0.83. The weekly and monthly volatility of the shares of Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) are indicated at 6.33% and 7.26%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 69.8.

While studying the financial position of the shares of Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), we can see that the Market capitalization of the company is at 684.9 Million. The shares outstanding for the company is 49.38 Million and the shares float stands at 49.38 Million. The income of the company stand at -71400000 while the sales stand at 1 Million.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at -3.43, Price to Earnings or P/E is at 0, Price to Sales P/S show the value of 684.9, the Return on Asset ROA stood at 0 and the Return on Equity ROE depicted at 0 while Return on Investment ROI is at -0.576.


The Clorox Company (NYSE:CLX)

The Clorox Company (NYSE:CLX) started its previous trading session at $131.61 and closed at $130.37 showing a Fell of -0.91 Percent.

The Company traded with an average Volume of 1.03 Million whereas, its Day Volume stood at 884736.

Looking at the performance of the stock, The Clorox Company (NYSE:CLX) Loss -1.93% in the last week in its shares price and 2.04% in the last month. Quarterly performance shows a red of -9.62 Percent while Semi-Annual and Annual performances shows a -2.74 and -5.58 percent respectively.

Beta for The Clorox Company (NYSE:CLX) stands at 0.36 while the ATR (average true range) is at 2.92. The Stock’s Weekly and Monthly Volatility is 1.78% and 2.04% respectively showing a RSI value of 45.31.

While studying the financial position of the shares of The Clorox Company (NYSE:CLX), we can see that the Market capitalization of the company is at 17.05 Billion. The shares outstanding for the company is 130.79 Million and the shares float stands at 129.27 Million.

The Company generated an income of 718 Million and the sales of 6.04 Billion in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $5.45 a share. P/E (price to earnings) and P/S (price to sales) values are 23.91 and 2.82 respectively.

The Return on Assets stands at 0.172, ROE shows a value of 1.389 and ROI for The Clorox Company (NYSE:CLX) is 0.257 as of Trailing Twelve Months period.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

    Leave a Comment